DINIX
Price
$20.40
Change
+$0.22 (+1.09%)
Updated
Apr 17 closing price
Net Assets
299.83M
FSGEX
Price
$14.84
Change
+$0.13 (+0.88%)
Updated
Apr 17 closing price
Net Assets
52.22B
Ad is loading...

DINIX vs FSGEX

Header iconDINIX vs FSGEX Comparison
Open Charts DINIX vs FSGEXBanner chart's image
BNY Mellon International Stock Index I
Price$20.40
Change+$0.22 (+1.09%)
VolumeN/A
Net Assets299.83M
Fidelity Series Global ex US Index
Price$14.84
Change+$0.13 (+0.88%)
VolumeN/A
Net Assets52.22B
DINIX vs FSGEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DINIX vs. FSGEX commentary
Apr 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DINIX is a Buy and FSGEX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
FSGEX has more cash in the bank: 52.2B vs. DINIX (300M). DINIX pays higher dividends than FSGEX: DINIX (3.21) vs FSGEX (2.81). DINIX was incepted earlier than FSGEX: DINIX (9 years) vs FSGEX (16 years). DINIX (0.36) is less costly to investors than FSGEX (0.01). DINIX is a more actively managed with annual turnover of: 3.67 vs. FSGEX (3.00). FSGEX has a lower initial minimum investment than DINIX: FSGEX (0) vs DINIX (1000). FSGEX (8.73) and DINIX (8.36) have marching annual gain over last year. FSGEX (57.34) and DINIX (55.19) have equivalent 5 years return.
DINIXFSGEXDINIX / FSGEX
Total Expense Ratio0.350.013,500%
Annual Report Gross Expense Ratio0.360.013,600%
Fund Existence9 years16 years-
Gain YTD5.6543.738151%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets300M52.2B1%
Annual Yield % from dividends3.212.81114%
Returns for 1 year8.368.7396%
Returns for 3 years14.6416.0391%
Returns for 5 years55.1957.3496%
Returns for 10 yearsN/A45.51-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JFNIX64.830.02
+0.03%
Janus Henderson Global Life Sciences I
NCLEX26.99N/A
N/A
Nicholas Limited Edition I
LGCFX15.84N/A
N/A
Lord Abbett Global Equity F
PAXLX11.23N/A
N/A
Impax Large Cap Fund Individual Investor
AXMIX13.37N/A
N/A
Acclivity Mid Cap Multi-Style I